LXEO
Price
$4.15
Change
-$0.11 (-2.58%)
Updated
Jul 18 closing price
Capitalization
224.03M
30 days until earnings call
RGNX
Price
$8.16
Change
-$0.53 (-6.10%)
Updated
Jul 18 closing price
Capitalization
411.17M
11 days until earnings call
Interact to see
Advertisement

LXEO vs RGNX

Header iconLXEO vs RGNX Comparison
Open Charts LXEO vs RGNXBanner chart's image
Lexeo Therapeutics
Price$4.15
Change-$0.11 (-2.58%)
Volume$227.92K
Capitalization224.03M
REGENXBIO
Price$8.16
Change-$0.53 (-6.10%)
Volume$744.17K
Capitalization411.17M
LXEO vs RGNX Comparison Chart in %
Loading...
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LXEO vs. RGNX commentary
Jul 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LXEO is a Hold and RGNX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 19, 2025
Stock price -- (LXEO: $4.26 vs. RGNX: $8.69)
Brand notoriety: LXEO and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LXEO: 66% vs. RGNX: 53%
Market capitalization -- LXEO: $224.03M vs. RGNX: $411.17M
LXEO [@Biotechnology] is valued at $224.03M. RGNX’s [@Biotechnology] market capitalization is $411.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LXEO’s FA Score shows that 0 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • LXEO’s FA Score: 0 green, 5 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, RGNX is a better buy in the long-term than LXEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LXEO’s TA Score shows that 3 TA indicator(s) are bullish while RGNX’s TA Score has 3 bullish TA indicator(s).

  • LXEO’s TA Score: 3 bullish, 4 bearish.
  • RGNX’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, LXEO is a better buy in the short-term than RGNX.

Price Growth

LXEO (@Biotechnology) experienced а -7.19% price change this week, while RGNX (@Biotechnology) price change was -4.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.49%. For the same industry, the average monthly price growth was +13.01%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

LXEO is expected to report earnings on Aug 18, 2025.

RGNX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGNX($411M) has a higher market cap than LXEO($224M). RGNX YTD gains are higher at: 12.419 vs. LXEO (-35.258). LXEO has higher annual earnings (EBITDA): -107.14M vs. RGNX (-122.44M). RGNX has more cash in the bank: 268M vs. LXEO (99.8M). LXEO has less debt than RGNX: LXEO (9.4M) vs RGNX (79.8M). RGNX has higher revenues than LXEO: RGNX (157M) vs LXEO (0).
LXEORGNXLXEO / RGNX
Capitalization224M411M55%
EBITDA-107.14M-122.44M88%
Gain YTD-35.25812.419-284%
P/E RatioN/AN/A-
Revenue0157M-
Total Cash99.8M268M37%
Total Debt9.4M79.8M12%
FUNDAMENTALS RATINGS
RGNX: Fundamental Ratings
RGNX
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
21
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LXEORGNX
RSI
ODDS (%)
Bearish Trend 4 days ago
82%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 9 days ago
84%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MYIDF0.090.01
+15.58%
Reklaim Ltd.
KNYJY32.380.63
+1.98%
Kone Oyj
EMFGF0.04N/A
N/A
Fluence Corp Ltd.
FUPPF42.99N/A
N/A
FUCHS SE
MPZZF1.70-0.04
-2.30%
MPC Container Ships AS